Document is current
Any future updates will be listed below
-
Authors
Su, Yapeng https://orcid.org/0000-0002-6305-8467
Ko, Melissa E.
Cheng, Hanjun
Zhu, Ronghui
Xue, Min
Wang, Jessica https://orcid.org/0000-0003-1421-4969
Lee, Jihoon W. https://orcid.org/0000-0002-6749-5111
Frankiw, Luke
Xu, Alexander
Wong, Stephanie
Robert, Lidia
Takata, Kaitlyn https://orcid.org/0000-0003-4864-9741
Yuan, Dan
Lu, Yue
Huang, Sui
Ribas, Antoni https://orcid.org/0000-0003-3669-8458
Levine, Raphael
Nolan, Garry P.
Wei, Wei https://orcid.org/0000-0002-1018-7708
Plevritis, Sylvia K.
Li, Guideng https://orcid.org/0000-0003-0840-7262
Baltimore, David https://orcid.org/0000-0001-8723-8190
Heath, James R. https://orcid.org/0000-0001-5356-4385
-
Funding
Funding for this research was provided by:
Sociedad Española de Oncología Médica (Fellowship)
Jean Perkins Foundation
- License Information
-
More Information
Article History
Received: 3 April 2019
Accepted: 2 April 2020
First Online: 11 May 2020
Competing interests
: J.R.H. and A.R. are affiliated with Isoplexis, which is seeking to commercialize the single-cell barcode chip technology. The remaining authors declare no competing interests.
